4-89721993-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000673902.1(SNCA):​c.390+7201G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.803 in 152,030 control chromosomes in the GnomAD database, including 49,971 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 49971 hom., cov: 31)

Consequence

SNCA
ENST00000673902.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0720

Publications

12 publications found
Variant links:
Genes affected
SNCA (HGNC:11138): (synuclein alpha) Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
SNCA Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • autosomal dominant Parkinson disease 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Lewy body dementia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000673902.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000673902.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNCA
ENST00000673902.1
c.390+7201G>A
intron
N/AENSP00000501102.1A0A669KB41
ENSG00000251095
ENST00000508021.5
TSL:4
n.448-4391C>T
intron
N/A
ENSG00000251095
ENST00000621944.1
TSL:5
n.91+1561C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.803
AC:
121994
AN:
151912
Hom.:
49914
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.949
Gnomad AMI
AF:
0.683
Gnomad AMR
AF:
0.818
Gnomad ASJ
AF:
0.743
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.861
Gnomad FIN
AF:
0.740
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.707
Gnomad OTH
AF:
0.780
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.803
AC:
122109
AN:
152030
Hom.:
49971
Cov.:
31
AF XY:
0.806
AC XY:
59887
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.949
AC:
39368
AN:
41478
American (AMR)
AF:
0.818
AC:
12489
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.743
AC:
2580
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5163
AN:
5170
South Asian (SAS)
AF:
0.859
AC:
4133
AN:
4814
European-Finnish (FIN)
AF:
0.740
AC:
7804
AN:
10546
Middle Eastern (MID)
AF:
0.840
AC:
247
AN:
294
European-Non Finnish (NFE)
AF:
0.707
AC:
48052
AN:
67972
Other (OTH)
AF:
0.782
AC:
1653
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1145
2291
3436
4582
5727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.737
Hom.:
19592
Bravo
AF:
0.814
Asia WGS
AF:
0.932
AC:
3238
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.3
DANN
Benign
0.66
PhyloP100
0.072

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs168552;
hg19: chr4-90643144;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.